SEMAGLUTIDE BASED DRUG

Novo's Bengaluru team drives diabetes drug

​The teams in Novo Nordisk Global Business Services (GBS) based in Bengaluru have collaborated with the global teams to contribute towards the Ozempic programme. Dawber said the Bengaluru team collaborates closely with the headquarters on the semaglutide drug, working on clinical trials, biostatistics, data management, pharmacovigilance, and global safety. Currently, it employs 4,000 employees.